Tokyo, Japan

Itsuro Shimada

This inventor holds 14 USPTO granted patents and 1 published patent application, plus 3 CIPO patents and 5 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Astellas Pharma Gmbh, Seldar Pharma Inc., Kotobuki Pharmaceutical Co Ltd. Active years: 2006-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Itsuro Shimada. Retrieved from https://idiyas.com/inventor/itsuro-shimada

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 14 

% Patents Active = 35.7

 

 

Average Co-Inventor Count = 9.7

ph-index = 5

Forward Citations = 139(Granted Patents)


Location History:

  • Tsukuba, JP (2006)
  • Chuo-ku, JP (2016)
  • Tokyo, JP (2011 - 2020)

Company Filing History:


Years Active: 2006-2020

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Quinazoline
Tetrahydroisoquinolin
Diamino Heterocyclic
Carboxamide
Pyrazinecarboxamide
Di(arylamino)aryl
Propane-1,3-dione
Triazole
Derivative
Salt
Compound
14 patents (USPTO):Explore Patents

Title: Innovations of Itsuro Shimada in Pharmaceutical Chemistry

Introduction

Itsuro Shimada is a prominent inventor based in Tokyo, Japan, known for his significant contributions to pharmaceutical chemistry. He holds a total of 14 patents, showcasing his innovative spirit and dedication to advancing medical science. His work primarily focuses on developing compounds that can serve as active ingredients in pharmaceutical compositions, particularly for treating serious health conditions such as lung cancer.

Latest Patents

One of his latest patents involves a quinazoline compound that is useful as an active ingredient in a pharmaceutical composition for treating lung cancer. The research conducted by Shimada and his team revealed that this quinazoline compound exhibits excellent G12C mutation KRAS inhibitory activity. This discovery positions the compound as a potential therapeutic agent for lung cancer, marking a significant advancement in cancer treatment options.

Career Highlights

Throughout his career, Itsuro Shimada has worked with notable companies in the pharmaceutical industry, including Astellas Pharma GmbH and Seldar Pharma Inc. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research and development.

Collaborations

Shimada has collaborated with esteemed colleagues such as Kyoichi Maeno and Hiroyuki Hisamichi. These partnerships have played a crucial role in enhancing the quality and impact of his research.

Conclusion

Itsuro Shimada's innovative work in developing pharmaceutical compounds, particularly for lung cancer treatment, underscores his importance in the field of medical research. His contributions continue to pave the way for new therapeutic options that can improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…